KRW 96700.0
(-6.84%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 189.5 Billion KRW | -24.96% |
2022 | 252.53 Billion KRW | -13.88% |
2021 | 293.23 Billion KRW | 115.75% |
2020 | 135.91 Billion KRW | -3.93% |
2019 | 141.47 Billion KRW | 16.26% |
2018 | 121.68 Billion KRW | 47.97% |
2017 | 82.23 Billion KRW | -8.17% |
2016 | 89.55 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 739.32 Billion KRW | -3.37% |
2024 Q1 | 765.09 Billion KRW | 303.74% |
2023 Q1 | 236.37 Billion KRW | -6.4% |
2023 Q4 | 189.5 Billion KRW | -5.34% |
2023 Q3 | 200.18 Billion KRW | -7.74% |
2023 Q2 | 216.97 Billion KRW | -8.21% |
2023 FY | 189.5 Billion KRW | -24.96% |
2022 Q3 | 274.84 Billion KRW | -1.92% |
2022 Q4 | 252.53 Billion KRW | -8.12% |
2022 Q2 | 280.21 Billion KRW | -1.96% |
2022 Q1 | 285.82 Billion KRW | -2.53% |
2021 Q3 | 268.46 Billion KRW | 0.0% |
2021 Q4 | 293.23 Billion KRW | 9.23% |
Name | Total Assets | Total Assets Difference |
---|---|---|
HLB Co., Ltd. | 751.72 Billion KRW | 74.791% |
iNtRON Biotechnology, Inc. | 98.61 Billion KRW | -92.164% |
BINEX Co., Ltd. | 257.01 Billion KRW | 26.267% |
Bioneer Corporation | 315.48 Billion KRW | 39.933% |
Anterogen.Co.,Ltd. | 149.43 Billion KRW | -26.815% |
MEDIPOST Co., Ltd. | 449.39 Billion KRW | 57.831% |
CrystalGenomics, Inc. | 243.11 Billion USD | 22.053% |
Helixmith Co., Ltd | 227.27 Billion KRW | 16.621% |
Chabiotech Co.,Ltd. | 1725.57 Billion KRW | 89.018% |
Medy-Tox Inc. | 611.62 Billion KRW | 69.016% |
Peptron, Inc. | 52.49 Billion KRW | -260.984% |
Amicogen, Inc. | 467.09 Billion KRW | 59.43% |
Genexine, Inc. | 376.58 Billion KRW | 49.679% |
HLB Therapeutics Co.,Ltd. | 200.79 Billion KRW | 5.624% |
ALTEOGEN Inc. | 256.09 Billion KRW | 26.005% |
PharmaResearch Co., Ltd. | 535.28 Billion KRW | 64.598% |
SillaJen, Inc. | 76.71 Billion KRW | -147.021% |
JETEMA, Co., Ltd. | 252.14 Billion KRW | 24.845% |
OliX Pharmaceuticals,Inc | 102.82 Billion KRW | -84.296% |
Genomictree Inc. | 132.84 Billion KRW | -42.65% |
MedPacto, Inc. | 80.47 Billion KRW | -135.481% |
D&D Pharmatech | 79.2 Billion KRW | -139.259% |
EASY BIO,Inc. | 172.04 Billion KRW | -10.149% |
GI Innovation, Inc. | 81.34 Billion KRW | -132.975% |